BiotechTube
Home/Vernagen/Baek Kim, PhD, RPh
BK

Baek Kim, PhD, RPh

Founder/CEO

Vernagen

Therapeutic Areas

Infectious DiseasesImmunological DisordersGenetic Disorders

Vernagen Pipeline

DrugIndicationPhase
mRNA Vaccine PlatformsVarious emerging pathogensPre-clinical
mRNA Biologics PlatformsImmunological and genetic disorders (protein replacement)Pre-clinical